+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
APPL APPL

Aptus Pharma Share Price

 

 

Aptus Pharma live price: ₹250.00. It opened at ₹253 vs previous close ₹248; intraday high/low: ₹260/₹245. The 50 DMA stands at ₹212.60.

Aptus Pharma Performance

  • Today's Low
  • ₹245
  • Today's High
  • ₹260
  • 52 Week Low
  • ₹32
  • 52 Week High
  • ₹260
  • Open Price₹253
  • Previous Close₹248
  • Volume25,600
  • 50 DMA₹212.60
  • 100 DMA₹178.80
  • 200 DMA-

Aptus Pharma Chart

Investment Returns

  • Over 1 Month + 13.46%
  • Over 3 Month + 68.01%
  • Over 6 Month + 180.33%

Smart Investing Starts Here Start SIP with Aptus Pharma for Steady Growth!

Invest Now

Aptus Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 92.8
  • PEG Ratio
  • -
  • Market Cap Cr
  • 429
  • P/B Ratio
  • 18.4
  • Average True Range
  • 9.6
  • EPS
  • 2.7
  • Dividend Yield
  • 0
  • MACD Signal
  • 9.5
  • RSI
  • 66.09
  • MFI
  • 77.17

Latest Stock News Updates

Aptus Pharma Ltd - 544529 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Aptus Pharma Ltd - 544529 - Announcement under Regulation 30 (LODR)-Credit Rating

Intimation Regarding Credit Rating assigned by CARE Ratings under Reluation 30 of SEBI (LODR) Regulations, 2015.

Aptus Pharma Ltd - 544529 - Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th June, 2026

Outcome of Board Meeting held on 12th June, 2026

Aptus Pharma Financials

Aptus Pharma Technicals

EMA & SMA

Current Price
₹250.00
+ 2.4 (0.97%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 14
  • 20 Day
  • ₹234.00
  • 50 Day
  • ₹212.60
  • 100 Day
  • ₹178.80
  • 200 Day
  • -

Resistance and Support

251.67 Pivot Speed
  • R3 274.00
  • R2 267.00
  • R1 259.10
  • S1 244.20
  • S2 237.20
  • S3 229.30

Aptus Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-06-12 Preferential Issue of shares & Others Inter-alia, to consider 1. Evaluate and deliberate upon the proposal for raising of funds. 2. If thought fit, to authorize the Managing Director of the Company. 3. Other business matters.
2026-04-27 Audited Results
2026-03-24 Bonus issue & Others Inter-alia, to consider 1. Increase in Authorized Share Capital subject to approval of members of the Company. 2. Other business matters.
2025-11-10 Half Yearly Results
Date Purpose Remarks
2026-05-12 Bonus Bonus issue of equity shares in the ratio of 3:2 of Rs. 10/-.

Aptus Pharma Shareholding Pattern

72.89%
27.11%
0%

Aptus Pharma FAQs

Aptus Pharma share price is ₹250 As on 21 July, 2026 | 19:11

The Market Cap of Aptus Pharma is ₹428.8 Cr As on 21 July, 2026 | 19:11

The P/E ratio of Aptus Pharma is 92.8 As on 21 July, 2026 | 19:11

The PB ratio of Aptus Pharma is 18.4 As on 21 July, 2026 | 19:11

The 52 week High & Low of Aptus Pharma is ₹260/₹32.3 respectively As on 21 July, 2026 | 19:11

Open FREE Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23